Objectives: To assess trends in die ordering of choles terol tests by general practitioners (GPs), and to assess whether the trend in ordering cholesterol tests is con sistent with the recommendations in the Dutch guide lines for GPs. Methods: Analysis of total cholesterol and lipid fraction tests at the Maastricht diagnostic centre, which serves all 85 GPs in the region* over the years 1984-1992. Main outcome measures are the number of cholesterol, HDL, LDL and triglyceride tests per year, and the num ber of cholesterol tests per GP per year. The frequency of cholesterol and lipid fraction testing in 'new patients' (patients presenting for cholesterol testing for the first time) are indicators for adherence to the guidelines on the diagnostic procedure. Data on new patients were available for the years 1989-1992. Results: There was an overall increase in the total num ber of cholesterol tests of 173% between 1984 and 1992. There is considerable and stable inter-doctor variation. In new patients, 13.5% of male and 23,0% of female patients did not fulfil the age criteria accord ing to the national guidelines. Repeat testing regarding diagnosis of hypercholesterolaemia as recommended was not performed in 86% of the new patients in 1989, which increased to 94% in 1992. Lipid fraction testing during the first contact with a new patient was not recommended; nevertheless this was done in 38% of the cases in 1989, decreasing to 31% in 1992. Conclusions: The strong increase in the number of cholesterol tests ordered over the years was accom-Trudy van der Weijden, research fellow. panied by a large and sustained inter-doctor variation in cholesterol testing. The diagnostic procedure improved slightly for lipid fraction testing, but deteri orated for repeat testing. Improvement on these topics should be sought, to prevent non-rational cholesterol management, which can have a relevant impact on the GP's workload and the resources of the public health system. In pursuing improvement, more attention should be given to effective implementation strategies as well as to the scientific validity of the guidelines.
Introduction
Important developments on the cholesterol issue took place in the 1980s. Results of large cholesterol interven tion studies were published, the H M G coenzyme-A reduc tase inhibitors were introduced, quickly followed by cho lesterol guidelines for all Dutch physicians.1'4 These devel opments, and the ongoing debate about the controversial character of cholesterol testing, have raised questions whether a specific trend in GPs' behaviour in ordering cho lesterol tests has developed over the last decade.5'7 Specific guidelines for cholesterol management in the gen eral practice setting were published by the Dutch College of GPs in November 1991/ Caution with regards to test ing characterises these guidelines; selective case finding is only indicated for people aged 18-65 years with an unfa vourable coronary risk profile. Diagnosis of hypercholes terolaemia requires the mean of three serum cholesterol tests to be higher than 6.5 mmol/L Determination of H DL and triglycerides is only indicated if cholesterol-lowering drugs are being considered. Considerable discrepancy between usual care and the guidelines was reported for Dutch GPs before publication of these guidelines/3 Simply disseminating cholesterol guidelines does not change daily practice. 10, 11 To promote implementation of new guidelines, more insight into ac tual behaviour of GPs is required. In many countries a low adherence to cholesterol guidelines by GPs has been re ported.1 2 '1 * A study of possible trends in ordering choles terol tests will further explore the relation between usual care and the guidelines. It might improve insight into pos sible external factors that have the power to influence GPs in their cholesterol management, or factors that restrain GPs from working according the guidelines.
ORIGINAL PAPER
The need for information on trends in the ordering of cho lesterol tests regarding implementation of the guidelines, together with the controversial character of cholesterol testing over the years, stimulated us to address the follow ing questions: 1 
Trends in cholesterol testing
To analyse the volume of test ordering in the course of time, the total number of tests per year for cholesterol, tri glycerides, H D L and LDL were extracted from the data base. The age and sex characteristics, the reasons for re quest, as well as the prevalence of hypercholesterolaemia were analysed in all patients. An increase in compliance with the recommendations specified by the Dutch guide lines should subsequently result in a decreased in ter-doc tor variation in ordering tests. For a trend analysis of in ter-doctor variation in ordering cholesterol tests, GPs who had not been participating for the whole year were ex cluded, still leaving an average of S I GPs per year for this analysis. Due to skewed distribution, inter-doctor vari ation was not expressed using means and standard devi ations, but using the median (= quartile 2 ) and quartiles 1 and 3 as indicators for inter-doctor variation. A higher in ter-doctor variation, expressed as the distance between quartile 1 (Ql) and quartile 3 (Q3), may just be the con sequence of an increasing median. Therefore we corrected the inter-doctor variation for the higher median by calcu lating the ratio (Q3-Ql)/median. Figure 1 illustrates the trend in the total number of total cholesterol, HDL, LDL and triglyceride tests in the Maas tricht region. There was an increase of 219% in choles terol testing in the period 1984-1990, which stabilised and slightly decreased by 21% in the period 1990-1992, result ing in an overall increase of 173% between 1984-1992. There were no clear trends in triglyceride and HDL-cholesterol testing. Triglyceride testing was performed about three times more often than HDL testing in this period. LDL testing was hardly observed. The age and sex distribution of the patients tested did not change during the nine-year period. Fifty-three percent of the patients tested were male (mean age 49 years, SD 12.9); the mean age of female patients was 55 years (SD 13.6). The prevalence of hypercholesterolaemia was already high in 1984 (51%), increased to 63% in 1987 and then de creased to 45% in 1992. bers, seems to have increased during the nine-year period. However, although rhe ratio (Q3-Ql)/median remains higher than 1.0 throughout the period, there was no clear increasing or decreasing trend in this ratio.
Trends in diagnostic performance related to the guidelines

Results
Trends in cholesterol testing
Trends in diagnostic performance related to the guidelines
The age and sex distribution of the new patients (patients presenting for cholesterol testing for the first time) did not change during this four-year period (table 1). On average 55% of the new patients were male, 13,5% of whom were not in the 18-65 age range which is the first criterion for selective case finding. Of the new female patients 23.0% did not fulfil the 18-65 age criterion. Table 2 illustrates the number of tests used to diagnose hy percholesterolaemia per new patient per year. Proper dia gnosis of hypercholesterolaemia was performed in 0.3-0.4% of the new patients. In 1989,13.7% of these patients had at least two cholesterol tests in a period of six months, which decreased to 6.4% of the patients in '1992. Figure  3 illustrates that in 1989, GPs requested HDL and trigly ceride testing in 38% of new patients, which is not indic ated according to the guidelines. This lipid fraction testing in new patients decreased to 31 % in 1992.
Discussion
Cholesterol testing by GPs affiliated to the Maastricht dia gnostic centre increased by 173% in the period 1984-1992. Inter-doctor variation remained high, even after sta bilisation of the increase in testing in 1990, despite publica tion of Dutch cholesterol guidelines in 1987 and 1991. There is considerable discrepancy between behaviour in ordering cholesterol tests and the guidelines. It is remark able that, while the evidence on the benefits of choles terol lowering is less for women than for men, relatively more women (23%) than men (13.5%) of 65 years and older are tested. 17 The poor and even deteriorating perform ance on repeat testing, which has also been reported else where, is alarming because insufficient repeat testing will impair the precision of diagnoses and the cost-effectiveness of cholesterol testing.l!U y Many forces seem to influence GPs1 behaviour in ordering cholesterol tests, despite the guidelines. Patients actively requesting cholesterol testing might be one of the important determinants of GPs1 be haviour in this field, as one in every five cholesterol tests were initiated by the patient in 1992 (the only year in which valid data could be collected on this aspect). It is clear that cholesterol testing is taking up far more of GPs' time and attention than 10 years ago. The high preval ence of hypercholesterolaemia gives an indication of the impact of cholesterol testing on the workload of GPs, be cause established hypercholesterolaemia consequently im plies intervening activities. Due to large amounts of missing clinical data on the test ordering form, no analyses could be done with the patient's coronary risk profile or reasons for request. The strength of the study is the quality of the data source; considering the high number of participating practices and the fact that no apparent shifts have occurred, the population was very stable throughout the years.20 The participating GPs were comparable to other Dutch GPs, except for the fact that GPs served by the Diagnostic Centre Maastricht have been provided twice yearly with individual feedback on selected behaviour in ordering tests (there has been no structural feedback on cholesterol diagnosis until now).2lul The vol ume of ordering these selected tests, as well as tests on * Diagnosis of hypercholesterolemia requires the mean of three serum cholesterol tests, determined m a period of six weeks, to be higher than 6 5 mmol/!. If the first test-value is lower than 5.0 mmol/I, or the mean of two values is lower than 6.5 mmol/!, there is no indication for (further) repetition of testing which no feedback was given, decreased compared to a ref erence diagnostic centre. The reference diagnostic centre showed a much steeper increase in cholesterol testing of 377% over the years [1984] [1985] [1986] [1987] [1988] [1989] [1990] , with a comparable sta bilisation in 1990. Therefore the trend found at the Maas tricht diagnostic centre seems to be an underestimation of the trends found in other Dutch diagnostic centres.
What are the implications of the results for implementa tion of the guidelines? The discrepancy between behaviour in ordering cholesterol tests and the guidelines does not necessarily mean a low quality of care. Guidelines imply little performance measurement, as medical practice re mains fundamentally an interpersonal experience, draw ing on the rich interaction between practitioner and pa tient.22 Physicians cite barriers for adherence to the guide lines such as: limitations in time, reimbursement, motiva tion and skills.2*'25 Based on the barriers to change, a com plex programme for improvement that meets prevailing administrative and reimbursement policies,2* is needed with a mix of several strategies for implementation; e.g. individualised feedback on GPs' behaviour in ordering tests, in combination with strategies such as an adjustment of the forms for ordering tests, peer discussions in small groups, or outreach visits from academically-qualified rep resentatives or local opinion leaders.2 1 0 To increase the likelihood of the guidelines changing medical practice, the feasibility of the guidelines should be discussed at local level/ 1 In addition to a discussion on the implementation of the guidelines, the results prompt a critical look at the scient ific validity of the guidelines. The ongoing debate about which high-risk groups benefit most by cholesterol screen ing needs clarification. It is remarkable that the practice guidelines that have been published internationally are conflicting in several aspects. Cholesterol guidelines seem to be influenced more by moral and economic factors than by evidence of health benefit. The method of develop ing the guidelines determines the scientific validity of the guidelines. 5 4 ' 1 ' Recently, a method for grading health care recommendations was proposed in which both scientific validity and cost-effectiveness considerations (number of patients that need to be treated) are combined.36'" We conclude that the strong increase in the number of cho lesterol tests ordered over the years was not accompanied by a decrease in inter-doctor variation and improvement in quality of testing. We recommend that improvement on these topics should be sought, to prevent non-rational cho lesterol management. In pursuing improvement, more at tention should be given to effective implementation strat egies as well as to the scientific validity of the guidelines. 
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